Sex-Dependent Effects of 7,8-Dihydroxyflavone on Metabolic Health Are Associated with Alterations in the Host Gut Microbiome

7,8-Dihydroxyflavone (DHF) is a naturally occurring flavonoid that has been reported to protect against a variety of pathologies. Chronic administration of DHF prevents high-fat diet (HFD)-induced obesity in female, but not male, mice. However, the mechanisms underlying this sexual dimorphism have not been elucidated. We have discovered that oral DHF supplementation significantly attenuates fat mass, hepatic lipid accumulation, and adipose tissue inflammation in female mice. In contrast, male mice were not protected from adiposity, and had a paradoxical worsening of hepatic lipid accumulation and adipose tissue inflammation upon DHF supplementation. Consistent with these sexually dimorphic effects on body weight and metabolic health, 7,8-DHF induced early and stable remodeling of the female intestinal microbiome. DHF supplementation significantly increased gut microbial diversity, and suppressed potentially detrimental bacteria, particularly Desulfovibrionaceae, which are pro-inflammatory and positively associated with obesity and inflammation. Changes in the female gut microbiome preceded alterations in body weights, and in silico analyses indicated that these early microbial changes were highly predictive of subsequent weight gain in female mice. While some alterations in the intestinal microbiome were also observed in male DHF-supplemented mice, these changes were distinct from those in females and, importantly, were not predictive of subsequent body weight changes in male animals. The temporality of microbial changes preceding alterations in body weight in female mice suggests a role for the gut microbiome in mediating the sexually dimorphic effects of DHF on body weight. Given the significant clinical interest in this flavonoid across a wide range of pathologies, further elucidation of these sexually dimorphic effects will aid the development of effective clinical therapies.     

充满型及非充满型胆囊结石粘膜病理形态及核仁组成区的研究

目的：探讨充满型及非充满型胆囊结石粘膜组织病理学的差异及相应外科治疗措施,方法：收集1995年10月至1996年10月期间的胆囊结石标本做常规病理染色及嗜银蛋白染色分析。结果：发现充满型及非充满型结石组胆囊粘膜不典型发生率及AgNOR数目均有显著差异。结论：一经诊断为充满型胆囊结石,特别是中老年肥胖妇女,应早期手术切除病变胆囊。     

人工流产术前宫颈及子宫内膜麻醉的镇痛效果探讨

目的　探讨宫颈与子宫内膜两部位联合麻醉、普鲁卡因与利多卡因两药物配合应用在人工流产术中的镇痛效果。方法　人工流产术前对麻醉组 10 6例行普鲁卡因宫颈浸润麻醉和利多卡因子宫内膜表面麻醉。术中记录受术者腹痛程度、无阻力插入宫颈内口的扩张器号、出血量、人流综合征例数等指标。按照世界卫生组织规定疼痛标准及人工流产综合征反应进行评价 ,同期选择按传统机械扩宫法 10 4例做对照。结果　麻醉组镇痛有效率95 3% ,宫口松驰有效率 95 3% ,人流综合征无 1例发生。两组比较P均 <0 0 0 1。两组出血量比较无差异 ,无利多卡因毒性反应发生。结论　人工流产术前普鲁卡因宫颈浸润麻醉和利多卡因子宫内膜表面麻醉镇痛效果显著 ,可大大降低人流综合征的发生 ,避免利多卡因的毒性反应     

病人自控硬膜外镇痛改善病人术后转归的研究

目的 研究PCEA对病人术后转归的影响。方法 100例均行硬膜外穿刺的手术,随机等分为两组即PCEA（A）组和未实施PCEA（B）组。定时监测两组MAP,HR,SPO2,RR;选择其中30例食管,胃肠道手术,除监测以上项目外,并于入手术室后硬膜外穿刺前（T0）,术始60分钟（T1）,术毕24小时（T2）时分别测定病人皮质醇,血糖,胃粘膜pH的变化情况。结果 A组镇痛期间MAP,HR,SPO2,RR,血糖,胃粘膜pH均变化不大,术后皮质醇浓度下降,镇痛确切,病人平干静合作,满意度高;B组镇痛期间除皮质醇浓度变化不大外,其余指标均波动明显,镇痛效果差,病人呈焦虑状态,满意度差。结论 PCEA利于病人术后转归。     

知觉性斜视31例临床分析

目的：探讨知觉性斜视的病因,临床特点,治疗方法及预后,方法：根据不同病情采取手术治疗,弱视训练及配戴三棱镜。结果：手术的29例眼位正,1例术后配戴三棱镜矫正眼位,1例先天性白内障术后经弱视训练视力改善后矫正眼位,24例无双眼单视功能,结论：及早发现各种引起知觉斜视的病因预以治疗,以促进双眼单视功能的发育。     

核素标记混合抗体瘤内注射治疗大肠癌的实验研究

目的:为临床应用混合抗体进行放射免疫治疗提供实验依据。方法:在裸鼠荷人大肠癌Lovo移植瘤生长至1cm时,瘤内分别或同时注射~(131)I标记的抗CL_3单克隆抗体(~(131)I-CL_3)和~(131)I标记抗FERR单克隆抗体T_9(~(131)I-T_9),治疗后行SPECT显像观察标记抗体在肿瘤内的浓聚,并进行疗效观察。结果:我们发现两种抗体混合治疗组疗效明显好于单独治疗组,抗体在肿瘤内的浓聚也大于单独应用。结论:多种抗体混合应用瘤内注射放射免疫治疗可增加标记抗体在肿瘤内的浓聚,并能提高放射免疫治疗的疗效。     

海南省山区霍乱流行病学分析

目的 为了解海南省山区的霍乱流行特点,为今后更好地预防、控制山区的霍乱流行提供理论依据。方法 采用统一制定的霍乱个案调查表和流行病学调查表进行调查,然后做统计分析。结果 1994～1998年,海南省山区发生6起食物型霍乱爆发疫情,发病191例,罹患率13．12％,病死6例,病死率3．14％。患者皆为黎族居民,各年龄组均有发病,以20～40岁组的青壮年所占比例最高,为67．54％。男性患者(65．97％)明显多于女性(34．03％)。疫情波及4个县(市)、8个乡(镇)、40个自然村。轻型病例仍然占大多数(62．30％)。对82株菌株的鉴定结果全部为小川lb型,与该省沿海地区自1994年后以小川1b型为优势流行株相一致。结论 导致这6起霍乱爆发的最主要原因是丧事聚餐,可疑食物均来自某市的海鱼。     

蜕皮甾酮对冠状动脉闭塞致大鼠心肌梗死的有益作用及机制

目的 探讨植物有效成分蜕皮甾酮（ecdysteron,EDS)对心肌梗死有益作用,并探讨其机制。方法 采用冠状动脉左前降支结扎致大鼠心肌梗死模型,ip EDS,连续7d。测定血清肌酸磷酸激酶（CPK）、谷草转氨酶（GOT）、乳酸脱氢酶（LDH）活性、心肌梗死面积、冠状动脉血清、毛细血管密度及血管内皮生长因子（VEGF）的表达量。结果 0．5,5,50mg/kgEDS能剂量能依赖地影响大鼠血清CPK、GOT、LDH活性,以5mg/kg剂量的EDS降低心肌酶谱为最佳。5mg/kgEDS能明显减少心肌梗死面积、增加冠状动脉血流量、毛细血管密度和VEGF表达量。结论 EDS能减轻冠状动脉结扎致心肌梗死,机制在于促进VEGF的表达和毛细血管再生及增加冠状动脉血流量。     

Study of the mechanism of essential garlic oil inhibiting lnterleukin-1 α-induced monocyte adhesion to endothelial cells

Objective  

To observe the effects of essential garlic oil (EGO) on vascular cell adhesive molecule-1 (VCAM-1) expression of endothelial cells and monocyte-endothelial cell adhesion rate induced by interleukin-l_α(IL-l_α).     

DNA拓扑异构酶I与肿瘤化疗

DNA拓扑异构酶 (topoisomerase ,TOPO )是一种基本的核酶 ,催化超螺旋结构的双链 DNA中某一条链的断裂和再接反应 ,从而改变 DNA的拓扑学状态 ,参与细胞DNA的复制和转录。TOPO 抑制剂是一类以 TOPO 为靶点的抗肿瘤药物 ,肿瘤细胞对 TOPO 抑制剂的耐药机制是复杂多样的 ,其中最主要的是 TOPO 基因突变和 TOPO 表达水平下降以及 TOPO 酶活性降低。笔者就近年来关于这方面的研究作一文献综述。1　 TOPO 及其抑制剂的作用机制人的 TOPO 是由 2 0号染色体上单拷贝基因编码的、分子量为 10 0 k Da的蛋白质。TOPO 催化 DN…